Have Anti–Tumor Necrosis Factor Agents Reduced Reoperation Need in Crohn Disease?

In Japan, the reoperation rate decreased significantly after 2002, when infliximab was introduced in practice.

Source link

Related posts

Private Care Program for U.S. Vets Gets $8.9 Billion in Budget Deal


Acidic Bile Salts Induce Epithelial to Mesenchymal Transition via VEGF Signaling in Non-Neoplastic Barrett’s Cells


An Unusual Cause of Lower Gastrointestinal Bleeding


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World